Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02872571 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy

Study acronym: AUTOGRAFTIM
StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Apr 2013 to Mar 2013v9
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 4 of 4 sites
    v8
  3. Primary and study completion dates: Apr 2022 to Apr 2026v7
  4. Study sites: 1 to 4v6
  5. 3 versions Re-verified since Feb 1, 2017, no change to tracked fieldsv3-v5
  6. Interventions: Intramuscular Islet Autograft (Procedure) to Intramuscular Islet Autograft (Drug)v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The liver may not be an optimal site for islet transplantation due to obstacles by an instant blood-mediated inflammatory response, and low revascularization of transplanted islets. Therefore, intramuscular islet transplantation offers an attractive alternative, based on its simplicity, enabling easier access for noninvasive graft imaging and cell explantation.
Trial Details
NCT Number NCT02872571
Lead Sponsor University Hospital, Lille
Conditions
(from sponsor)		 Disorder of Endocrine Pancreas
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov